Biotech research body expected to boost innovation

Image
Itishree Samal Hyderabad
Last Updated : Jan 20 2013 | 3:11 AM IST

The Biotechnology Industry Research Assistance Council (BIRAC), which got the Union Cabinet’s approval in November 2011, is gearing up to be fully operational by the next financial year.

“BIRAC, which is now known as BIRAP (Biotechnology Industry Research Assistance Programme), is in the pilot stage in Delhi. It is expected to be fully operational by the next financial year,” S R Rao, adviser to the department of biotechnology (DBT), told Business Standard.

BIRAC, a not-for-profit Section 25 company, was set up as a separate body by the DBT to enhance the strategic research and innovation capacity of biotech companies – especially SMEs – in India. The council will operate with an initial outlay of Rs 70 crore for two years, Rao said.

It will serve as a single window for the emerging biotech industry. It will help in technology management, support services such as IP facilitation, legal matters and contracts, clinical trail facilitation, mentoring and capacity building, and in creating affordable products and services.

Rao said the $4 billion biotechnology market in India was growing at 21 per cent year-on-year. The ecosystem consists of 20-30 large companies and more than 300 SMEs.

“SMEs in biotech are doing well in R&D and product development. Some SMEs, strong in innovation and R&D, have even been acquired by large companies. For example, the Bangalore-based product development company Metahelix Life Sciences was acquired by Rallis India, a subsidiary of Tata Chemicals, in 2010,” Rao said.

Funding for the biotech sector has increased substantially over the years, from Rs 2,000 crore in the 10th Five Year Plan to Rs 6,300 crore in the 11th Plan.

“The R&D budget in science and technology is expected to be doubled in the 12th Plan to two per cent of the gross domestic product (GDP),” he said. The government has taken initiatives such as the Small Business Innovation Business Research Initiative (SBIRI) – where the government allows grants of up to Rs 50 lakh and provides loans at a subsidised rate – and the Biotechnology Industry Partnership Programme (BIPP) to support SMEs. Over 100 companies and 50 projects have been funded under the SBIRI and BIPP respectively, Rao said.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 20 2012 | 12:47 AM IST

Next Story